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SPECIAL REPORT
The classification of self-inflicted skin lesions proposed 
by the European Society for Dermatology and Psychiatry 
(ESDaP) group generated questions with regard to 
specific treatments that could be recommended for 
such cases. The therapeutic guidelines in the current 
paper integrate new psychotherapies and psychotropic 
drugs without forgetting the most important relational 
characteristics required for dealing with people with 
these disorders. The management of self-inflicted skin 
lesions necessitates empathy and a doctor–patient re-
lationship based on trust and confidence. Cognitive be-
havioural therapy and/or psychodynamic and psycho-
analytic psychotherapy (alone, or combined with the 
careful use of psychotropic drugs) seem to achieve the 
best results in the most difficult cases. Relatively new 
therapeutic techniques, such as habit reversal and 
mentalization-based psychotherapy, may be beneficial 
in the treatment of skin picking syndromes.
Key words: self-inflicted injury; skin picking disorder; psycho-
logical treatment; doctor–patient relationship; clinical practice 
guidelines.
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Self-harming behaviour has many aspects. In 2013, the European Society for Dermatology and Psychiatry 
(ESDaP) group (1) proposed a terminology and clas-
sification of self-inflicted skin lesions (SISL), which 
included several aspects of self-harm behaviour to the 
skin. Recent studies have indicated the acceptance of the 
classification with regard to therapeutic approaches to the 
treatment of patients with skin conditions (2). The Diag-
nostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5), published in May 2013 (3), includes 
“skin picking” as a new category within the spectrum of 
obsessive-compulsive and related disorders. SISL have 
been described as a non-suicidal, conscious and direct 
damage to the skin (4–7).
In the previous classification paper from the ESDaP 
group, there was an explanation as to why SISL should 
not encompass all skin lesions attributed to pathologi-
cal behaviour (1). In psychiatric practice, classification 
traditionally requires that when a symptom or a set 
of symptoms is better explained by a well-identified 
mental disorder, the diagnosis should be related to that 
psychiatric disorder. Self-mutilations may therefore 
occur in a spectrum of primarily psychiatric diagnoses. 
For example, in autistic spectrum disorders (8), schi-
zophrenia (9) or mental retardation (10), as well as in 
Tourette and chronic tic disorders (11), Lesch-Nyhan 
(12, 13) or Prader-Willi (14, 15) genetically determined 
syndromes, with their neurological, behavioural and/or 
metabolic abnormalities. Consequently, self-mutilations 
seen in these psychiatric or neurological disorders 
should not be included in the restricted category of SISL, 
although a dermatological consultation and treatment 
may be required in all these conditions and some of the 
behavioural or pharmacological therapeutic approaches 
recommended in SISL could also be effective. The 
same principle should be applied to skin damage due to 
phlebotomy suicide attempts, skin or even deeper body 
self-injury seen in patients with various body delusions 
or hallucinations. The potential dermatological thera-
peutic approach of these patients is outside the scope 
of this article.
In its previous paper, the ESDaP group displayed the 
rationale of the proposed classification based on the 
answers to an initial question: “Is the behaviour respon-
sible for the somatic damage denied or kept secret by 
the patient?” If the answer to this question is affirmative, 
the next question should be: “Are there any external in-
centives?”, thereby differentiating between malingering 
and factitious disorders. If the answer to the question is 
negative, the next question should be: “Is the behaviour 
responsible for the somatic damage compulsive or im-
pulsive?”, thereby differentiating be tween 2 different 
categories of skin picking disorders. This step-by-step 
classification tree helps to describe different categories 
within the set of SISL, as the purpose of both the pre-
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vious paper and the current one is to help dermatologists 
identify and treat these syndromes. Most dermatological 
research published SISL are mainly dedicated to only 
one category, this being the compulsive spectrum of skin 
picking syndromes: “trichotillomania” or compulsive 
hair pulling, acne excoriée, etc. Moreover, as the new 
DSM-5 classification individualizes and includes “skin 
picking” within the spectrum of obsessive-compulsive 
disorders (OCD), the other category of skin picking, i.e. 
the impulsive one, does not belong to this diagnostic 
class and is supposed to constitute a clinical expression 
of different psychiatric diagnoses, such as borderline 
personality disorder.
There is evidence that SISL are more prevalent than 
previously believed: a 2010 study suggested that approx-
imately 1.4% of adults in the USA are sufferers (16); a 
recent Canadian study concluded that the life-time preva-
lence of skin picking in young people was approximately 
18% (17) and in 2013, in a German sample of 266 school 
children, 19.6% admitted occasional skin picking, with 
1.9% regularly indulging in this behaviour and presenting 
clear stress regulation difficulties (18). 
Dermatologists are therefore regularly called upon to 
treat patients who exhibit symptoms of SISL. The aim of 
this paper is to provide skin specialists not familiar with 
the psychiatric classification system (and/or behavioural 
disorders) with some stratified therapeutic principles on 
the taxonomy of the aforementioned lesions (1). The role 
of dermatologists is predominant in the management 
of patients with combined dermatological and mental 
disorders. Nevertheless, our purpose is not to encourage 
dermatologists to prescribe a wide range of psychotropic 
drugs or to engage in structured psychotherapeutic in-
terventions without any specific training, but to provide 
them with some landmarks for better managing this 
kind of patients, in collaboration with mental health 
specialists. The therapeutic recommendations of the 
ESDaP group are derived both from evidence-based data, 
where available, and from the clinical experience of this 
multidisciplinary group of specialists. 
Readers should bear in mind that certain categories 
of SISL, such as factitious disorders, are not suitable for 
systematic studies on the efficacy of different therapeutic 
approaches, due to the fact that they are relatively rare 
disorders, as well as for ethical reasons. Nevertheless, 
these clinical manifestations pose difficult problems and 
should be managed by well-informed dermatologists.
GENERAL PRINCIPLES FOR THE MANAGEMENT 
OF SELF-INFLICTED SKIN LESIONS 
Awareness
For the correct management of SISL, dermatologists 
should be aware of the importance of the psychological 
suffering that generally underlies this behaviour. Diag-
nosis and treatment of the skin lesions are often the 
first steps for the dermatologist, but simply treating the 
lesion does not deal with the psychological suffering, 
often requiring a multidisciplinary approach involving 
mental health professionals. A multidisciplinary ap-
proach implies a combination or a succession of diffe-
rent therapies: dermatological treatment, psychotropic 
drugs, cognitive-behavioural therapy (CBT) and other 
psychotherapies, such as psychodynamic psycho therapy 
or even psychoanalysis. 
The basis for the management of all types of SISL is 
the patient–doctor relationship; its establishment may 
depend on experience with SISL patients, knowledge 
of psychodermatology and participation in a so-called 
Balint-group (19). Good listening skills, the ability to 
demonstrate empathy, and to engage in non-judgemental 
communication are other important qualities for the 
therapist. Treating SISL patients can be very difficult 
as they are often unaware of the psychological causes 
behind their symptoms or not cognisant of the link bet-
ween their psychological suffering and their pathological 
behaviour. This lack of awareness is a significant obstacle 
to the establishment of a therapeutic alliance.
Feelings of frustration and discouragement are com-
mon among dermatologists treating SISL patients; sub-
jects often show little or no improvement, and they may 
even present more or worsening symptoms. 
Despite these difficulties, improvements in patients’ 
conditions can be a source of gratification for both der-
matologists and psychotherapists. The worst therapeutic 
approach is to refuse to treat these patients, immediately 
referring them to a mental health professional, even 
before having established any kind of doctor–patient 
relationship. Patients need to understand their situation 
and have to be motivated before they start working with 
the mental health team. A therapeutic approach to the 
management of SISL can be made easier if the specialist 
has background knowledge as to why a human being is 
capable of self-harm. 
Nock (7) developed an integrated theoretical model of 
the development and maintenance of self-harm, including 
risk factors and biographical aspects. The following hy-
potheses on the underlying mechanisms were proposed:
• a social learning hypothesis: recognition of others 
doing the same. 
• a self-punishment hypothesis: the behaviour results 
from feelings of shame, guilt and self-hate.
• a social signalling hypothesis: SISL have an interper-
sonal function (seeking psychological help). 
• an implicit identification hypothesis: identifying with 
non-suicidal self-injury to the point of using it to re-
gulate emotions.
• a pain-analgesia or opiate hypothesis: the role of pain 
tolerance as a dispositional risk factor or a consequence 
of repeated self-injury.
• a pragmatic hypothesis: the use of SISL as a relatively 
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fast and easily accessible method for regulation of 
negative emotions.
• a tension-regulation hypothesis: self-harm can occur 
in conditions of intolerable tension and induce an im-
mediate relief.
Preparing the patient for a multidisciplinary approach
The dermatologist can suggest that the problem is not 
only physical (the skin), but that there might be other 
causes. Patients will often accept the possibility that the 
symptoms are aggravated by stressful situations in daily 
life. A basic physiological discussion on stress-reactions 
on the skin and the activation of skin nerves would be 
one of the first steps in a psychoeducational approach to 
motivating the patient to consider broader-based treat-
ments. A clear statement about the complexity (not the 
difficulty) of the patients’ case is also recommended. A 
non-confrontational discussion on how and when the 
lesions appeared, and the suggestion that the patient may 
aggravate the injuries through their own actions, can be 
a way of determining the person’s awareness of their 
self-harm behaviour. 
Some patients may comment on (or the physician will 
suspect) suicidal ideation. In these cases, co operation 
with a mental health specialist is recommended. If ac-
cess to a mental health professional is not possible or 
the patient refuses a referral, the dermatologist must 
determine if the patient’s feelings are limited to suicidal 
ideation or if there is a specific intention to commit sui-
cide. If there is an intent, psychiatric treatment must be 
offered; in extreme situations, the physician should feel 
justified in forcing the subject to undergo a psychiatric 
examination, even without consent (depending on the 
legal structure in the country in question). For such a 
purpose, collaboration with the general practitioner can 
be essential. 
Even when the dermatologist has carried out and cor-
rectly applied these management techniques, there will 
still be some individuals who will refuse any kind of 
psychiatric treatment. Based on members’ experience, 
the ESDaP group estimate that this may occur in as many 
as 15–30% of SISL patients. The maintenance of the 
therapeutic relationship could, in the medium-to-long 
term, convince these patients to change their opinion.
THERAPEUTIC APPROACHES (Table I)
There are a number of therapeutic approaches that can 
be applied to SISL. For the dermatologist, the first step 
is the dermatological treatment of the skin lesions; a 
further priority is the establishment of a good doctor–
patient relationship. The indications of the pharmaco-
logical and non-pharmacological approaches described 
hereafter depend on the type of the disorder. Several 
of these approaches can be combined, especially in the 
more difficult patients or in a second-line treatment. 
Most importantly, a multidisciplinary approach is often 
appropriate.
Dermatological treatment
Treating the skin and using technical approaches, such 
as wound healing therapy, can give the dermatologist 
the opportunity to begin to develop a communicative 
relationship with the patient and encourage them to talk 
about other issues in their lives. The use of basic topical 
treatments and emollients can sometimes help lower 
the resistance of patients to talk about other topics be-
yond the skin lesions. Starting by concentrating on the 
treatment of the skin lesions can be less threatening or 
intimidating for the patient who would prefer to avoid 
speaking about self-harm and repressed emotions. It is 
helpful to continue the dermatological treatment in the 
follow-up consultations: many patients criticise or reject 
an already started psychological approach by a mental 
health professional when faced with difficulties or the 
lack of apparent progress. A trusting dermatological rela-
tionship can be a resource for motivating an ambivalent 
patient to continue psychosomatic–psychi atric treatment. 
Involving other health professionals (e.g. nurses) may 
offer additional contact for the patients. Conversation 
will be of a different kind and this can be useful for 
gathering information and observing behavioural charac-
teristics; for example, an aversion to physical contact (in 
some cases this might be a symptom of physical or sexual 
abuse and/or a post-traumatic stress disorder (PTSD)). 
The use of indirect speech, by referring to other 
patients’ emotional conflicts and skin disorders, can 
provide information about the sufferer’s awareness or 
readiness to talk about underlying problems. This can 
also give an indication as to the effectiveness of a psycho-
dermatological approach. 
Psychotropic drugs (20)
Antidepressants (Table II). The antidepressants com-
monly used in dermatology are: tricyclic antidepressants 
(TCAs) (amitriptyline, clomipramine, doxepin); tetracy-
clic antidepressants – (TeCAs) (mirtazapine); selective 
serotonin reuptake inhibitors (SSRIs) (fluoxetine, pa-
roxetine, fluvoxamine, citalopram, escitalopram, sertra-
line); selective serotonin and norepinephrine reuptake 
inhibitors (SSNRIs) (venlafaxine, duloxetine); serotonin 
modulators (trazodone); and dopamine-norepinephrine 
reuptake inhibitors (DNRI) (bupropion). Antidepressants 
need at least 2–3 weeks to take effect. The physician 
must be aware of the fact that an anxiolytic effect and 
the removal of the inhibition component of depression 
generally precede the specific effect on mood and this 
may therefore, in rare cases, precipitate a suicide attempt. 
Dermatologists and other health professionals should 
bear in mind that by not treating a severely depressed 
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patient the risk of suicide is much higher than prescribing 
an antidepressant with disinhibitory properties. Such a 
cost-benefit assessment might help dermatologists con-
front a patient presenting with both SISL and depressive 
symptoms. 
TCAs are long-established and efficacious antide-
pressants, but they are less used nowadays due to their 
adverse effects. The most commonly used TCA in 
dermatology is doxepin, which has a potent H1 and H2 
histamine-blocking activity and represents the first-line 
“off-label” treatment for psychogenic excoriations and 
SISL linked to pruritus. Lower dosages of doxepin have 
anti-pruritic and sedative effects, but the antidepressant 
effect is limited.
Mirtazapine is a TeCA, which antagonizes adrenergic 
α2-auto- and α2-heteroreceptors as well as 5-HT2 and 
5-HT3 receptors and can have significant effects on 
pruritus. Mirtazapine has a high affinity to central and 
peripheral histamine H1 receptors (21, 22). However, an 
adverse effect is weight gain.
SSRIs and SSNRIs are currently the most prescribed 
antidepressants due to tolerability and a favourable side-
effect profile. A serotonin syndrome can develop when 
serotoninergic drugs, such as SSRIs and SSNRIs, are 
used concomitantly with monoamine oxidase inhibitors, 
triptans (e.g. sumatriptan for migraine treatment), anti-
dopaminergic agents (e.g. metoclopramide for nausea) 
or antipsychotics (e.g. risperidone).
TCAs and SSRIs have other properties and are used 
in: panic disorder, OCD, PTSD, social phobia and ge-
neralized anxiety disorder. The fact that they are anti-
compulsive means that they are a first-line treatment for 
all compulsive-type SISL as well as when an obsessive 
concern for body image contributes to skin picking 
behaviour.
N-acetyl cysteine. N-acetyl cysteine (NAC) is a glu-
tamate modulator that has the property of ameliorating 
oxidative stress and has demonstrated promising effects 
in the treatment of OCD (23). Recent results in obsessive-
compulsive related disorders, such as trichotillomania 
or compulsive type skin picking disorders, have to be 
replicated (24, 25). 
Antipsychotics. The antipsychotics most commonly used 
in dermatology are typical antipsychotics (first genera-
tion) such as haloperidol or pimozide, and atypical 
Table I. Overview of therapeutic approaches in self-inflicted skin lesions (SISL)
Category Characteristics Main indications
Dermatological treatment Wound-healing techniques, topical treatments and emollients. Basic 
treatment of the underlying disease, when needed (e.g. 
in acne excoriée).
Always recommended, even during the follow-up and when the 
referral to a mental health specialist was accepted and proved 
helpful. Especially useful for lowering resistances to a psychological 
approach and preparing referral.
Psychotropic drugs
Antidepressants They need at least 2–3 weeks to take effect. The removal of 
the inhibition component of depression generally precedes 
the specific effect on mood and this may therefore precipitate 
a suicide attempt.
SISL complicated by or facilitated by a depressive state, 
compulsive type skin picking and related skin damaging 
symptoms, SISL with an obsessive concern for body image or 
complicated by social phobias.
N-acetyl cysteine A glutamate modulator with the property of ameliorating oxidative 
stress.
Obsessive compulsive and related disorders, such as 
trichotillomania and compulsive type skin picking.
Antipsychotics They generally need a referral to or at least an advice of a 
psychiatrist. Risk of poor adherence, due to side-effects.
Severe obsessive-compulsive disorder or impulsiveness and 
tendency to repeat self-harm associated with SISL.
Anticonvulsive drugs Compulsory psychiatric follow-up. Mood disorders, especially bipolar disorder, when associated with 
SISL, or associated borderline personality disorder.
Anti-opioids Unusual prescription. Severe pruritus.
Benzodiazepines Too frequently prescribed, but short-term prescription 
recommendations rarely respected. Dependency and 
withdrawal syndromes.
Anxiolytic effect. Watch for a paradoxical removal of inhibition in 
patients with personality disorders.
Psychotherapeutic approaches
Psychodynamic 
psychotherapy
Patient’s free associations encouraged. Focused on uncon scious 
processes. Childhood experiences, personal fantasies and dreams 
are analysed. Transference and counter-trans ference play a  
major role.
Associated personality disorders. Childhood traumas and life 
adverse experiences. Patient’s motivation for exploring his/her 
psychic life.
Mentalization-based 
treatment
18 months, with weekly individual sessions and additional group 
work.
Patients with borderline personality disorders, easily overwhelmed 
by their emotional states.
Eye movement 
desensitization and 
reprocessing
Cognitive-behavioural technique, developed in post-traumatic  
stress disorders. Short treatment duration.
Impulsive type skin picking and related skin damaging symptoms. 
Adverse life experiences in childhood, household dysfunction, 
bullying and humiliation.
Mindfulness Links with meditation techniques. Non-judgmental acceptance 
of somatic sensations, physical pain, thoughts, memories, or 
psychological distress. Short treatment duration. Training relay by 
personal home exercises.
Patient’s desire to better manage stressful situations.
Third-wave cognitive 
behavioural therapy
Comprehensive therapies, including some approaches derived  
from psychodynamic psychotherapy.
SISL associated with obsessive compulsive disorders or body 
dysmorphic disorder. Self-inflicted excoriations.
Transference-focused 
psychotherapy
Manualized treatment for severe personality disorders, based on 
psychoanalytic object relations theory.
SISL associated with borderline personality disorders.
Psychoeducation Encompasses patient’s information, relaxation techniques, and 
problem-solving recommendations. Not really tested in SILS.
Useful in compulsive type skin picking and related skin damaging 
symptoms.
Relaxation techniques Focused on bodily sensations. Efficacy per se not proved in SISL. Often integrated in more complex cognitive behavioural techniques 
or comprehensive psychotherapeutic approaches proposed in SISL.
Other indications in dermatology other than SISL, for example, delusional parasitosis or glossodynia, are not mentioned in this Table.
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antipsychotics (second and third generation) such as ris-
peridone, olanzapine, and aripiprazole. First-generation 
antipsychotics have several side-effects (extrapyramidal 
side-effects, orthostatic hypotension, blurred vision, 
constipation, urinary hesitancy, galactorrhea and ame-
norrhea). This has limited their use and explains the low 
treatment adherence (or interruption of the treatment) 
on the part of the patients. This must be taken into ac-
count with patients who are reluctant to recognize the 
psychological component of their problem. Second- and 
third-generation antipsychotics are better tolerated (less 
extrapyramidal effects), even though many of them have 
metabolic side-effects, including weight gain, hypergly-
caemia, diabetes mellitus and lipid abnormalities. 
Antipsychotics are prescribed in dermatology for 
treating delusory parasitosis, severe OCD associated 
with SISL or the impulsiveness and tendency to repeat 
self-harm that is also associated with SISL. In these cases, 
the involvement of a psychiatrist is highly recommended.
Anticonvulsive drugs. Anticonvulsive drugs (lithium 
salts, carbamazepine, oxcarbamazepine, valproic acid, 
lamotrigine, etc.) are commonly used in psychiatry for 
treating mood disorders (especially bipolar disorder), 
as an augmentation strategy for depression resistant 
to antidepressants and for severe affective regulation 
problems and the behaviour instability usually present 
in borderline personality disorders. Side-effects include 
weight gain, acne conglobata, hidradenitis suppurativa 
and psoriasis (with lithium therapy); erythema multi-
forme and Stevens-Johnson syndrome (with carbamaze-
pine and lamotrigine). They can, nevertheless, be useful 
in some conditions associated with SISL, but require 
considered prescription and follow-up by trained mental 
health professionals.
Anti-opioids. Naltrexone has positive effects in syn-
dromes associated with severe pruritus (see European 
guidelines for pruritus treatment (26)).
Benzodiazepines. Benzodiazepines are the most com-
monly prescribed anxiolytic drugs. Short-term prescrip-
tions are recommended but rarely respected. Side-effects 
(sedation, alcohol intolerance, lack of concentration, 
driving disturbances, agitation, sexual dysfunction), the 
frequency of withdrawal symptoms (depression, seizu-
res, autonomic nervous system disturbances), rebound 
symptoms (anxiety, sleep disturbances, restlessness) and 
the risk of dependence or abuse should be taken into ac-
count, especially for patients with personality disorders. 
A paradoxical removal of inhibition can be observed 
and should be watched for, especially in patients with 
personality disorders, facilitating self-harm behaviour.
Psychotherapeutic approaches
Psychodynamic psychotherapy. The concept of psy-
chodynamic therapy has its origins in psychoanalytic 
theory. Psychodynamic therapy is also known as “insight-
oriented therapy” and focuses on unconscious processes 
as they are manifested in a person’s behaviour. Analysis 
of early childhood experiences, as well as personal fan-
tasies and dreams, can help improving self-awareness 
and understanding the influence of the past on present 
behaviour.
Psychodynamic therapy uses free association in a 
non-judgmental environment and takes advantage of 
transference and counter transference phenomena. 
“Transference” refers to the patient and is the repetition, 
in adulthood, of modes of relating to others (including 
doctors and psychotherapists), which were formed in 
infancy during early bonding (27). “Countertransference” 
concerns the doctor’s emotional, conscious and uncons-
cious reaction to the subject, in accordance with his or 
her own family, personal and professional experience.
Whilst psychodynamic therapy is one of the psycho-
therapeutic techniques that can be used as such, more 
specific and sometimes even manualized psychody-
Table II. Antidepressants
Class General data and management rules Principal side-effects
Tricyclic antidepressants (TCAs) Long-established and efficacious, but less used nowadays 
due to their adverse effects. Some TCAs, especially doxepin, 
have potent H1 and H2 histamine-blocking activity, useful in 
SISL linked to pruritus. Harmful in case of suicide attempt, 
due to their cardiac toxicity.
Anticholinergic effects: sedation, dry mouth, urine retention, 
decreased gastrointestinal motility, blurred vision, narrow-
angle glaucoma; adrenolytic effects: orthostatic hypotension; 
lowering of the seizure threshold and cardiac disturbances 
that include QTc interval prolongation, conduction 
abnormalities and arrhythmias.
Tetracyclic antidepressants (TeCAs) Easier to manage than TCAs. High affinity for central and 
peripheral histamine H1 receptors. Usefulness of mirtazapine 
in pruritus associated SISL.
Weight gain.
Selective serotonin reuptake inhibitors 
(SSRIs)
The most used antidepressants nowadays, with SSNRIs. 
Be careful when used concomitantly with monoamine 
oxidase inhibitors, triptans (e.g. sumatriptan for migraine 
treatment), antidopaminergic agents (e.g. metoclopramide 
for nausea) or antipsychotics (e.g. risperidone). Useful in 
compulsive spectrum disorders.
Sleep changes, sexual dysfunction and gastrointestinal 
disturbances such as constipation, diarrhoea, nausea and 
vomiting. Hyponatraemia. Possible serotonin syndrome 
when additional serotoninergic agents are prescribed. Drug 
interactions caused by hepatic metabolism through the 
cytochrome P450 pathway.
Selective serotonin and norepine phrine 
reuptake inhibitors (SSNRIs)
The most used antidepressants nowadays, with SSRIs. 
Useful in somatic painful syndromes.
Same side-effects than with SSRIs. Increased sweating. Blood 
pressure raise.
Serotonin modulators For example, trazodone. Similar but fewer anticholinergic and adrenolytic effects than 
TCAs and less cardiotoxicity.
Dopamine-norepinephrine reuptake 
inhibitors (DNRI)
For example, bupropion. Also used to help people quit 
smoking.
Anxiety, irritability, restlessness, trouble sleeping, shaking, 
hyperventilation, increased sweating, dry mouth, unusual 
weight loss. Blood pressure raise.
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namic techniques have been applied and tested with 
patients with SISL or other underlying psychiatric 
disorders (28).
At this stage it should be mentioned that the legi-
timacy of integrating a psychodynamic approach in an 
evidence-based practice of medicine is a long-debated 
issue. Nonetheless, the evidence for the efficacy of such 
approach is increasing (29).
Mentalization-based treatment (MBT) (30) was deve-
loped for patients with borderline personality disorders. 
It is based on the idea that the consideration of mental 
states, in oneself and others, should lead to a better un-
derstanding and management of one’s self-harm beha-
viour. The goal of psychodynamic psychotherapy is for 
the subject to be able to deal with the mentalization of 
thoughts and emotions, especially in emotionally tense 
situations. Therapy takes place over 18 months, with 
weekly individual sessions and additional group work. 
In randomized-controlled studies (31) with an 8-year 
follow-up, efficacy was demonstrated by a lower number 
of suicide attempts (32). 
Eye movement desensitization and reprocessing (EMDR) 
is a psychotherapeutic method developed for the treat-
ment of trauma victims (33). In a recent article, Shapiro 
(34) reviewed all the randomized studies on EMDR th-
erapy in treating psychological and somatic disorders and 
concluded that the technique can be successful in dealing 
with physically aggressive behaviour (pushing, grabbing, 
shoving, slapping, hitting). These are behaviours that are 
related to adverse life experiences in childhood, hous-
ehold dysfunction, bullying and humiliation. It has also 
been suggested that EMDR is useful for treating women 
who have experienced sexual violence (35).
Mindfulness is inspired by Buddhism and based on the 
non-judgmental acceptance of somatic sensations, phy-
sical pain, thoughts, memories, or psychological distress. 
There are 4 mechanisms: attention regulation, body 
awareness, emotional regulation, and change in one’s 
self-perspective (36). Mindfulness has been described 
as effective with somatization disorders, addictive be-
haviour, bodily distress syndrome (37) and PTSD (38). 
Third-wave cognitive behavioural therapy. The “first 
wave” comprised the scientific behavioural therapies 
developed from the 1950s to the 1980s; the “second 
wave” is considered to be the CBTs that were popular 
between 1980 and 1990; nowadays, the “third wave” 
is denominated as a group of cognitive-emotional be-
havioural therapies that include: acceptance and com-
mitment therapy (Hayes); schema therapy (Young), 
dialectical behaviour therapy (Linehan); cognitive be-
havioural analysis system of psychotherapy; functional 
analytic psychotherapy; and integrative behavioural 
couple therapy (39). Schema therapy has been used with 
OCD (40) and small-group intensive CBT was found to 
improve OCD symptoms and cingulate neurochemistry 
(41). Furthermore, it has been argued that it is more 
effective than anxiety management in treating body 
dysmorphic disorders (BDD) (42). 
Self-inflicted excoriations have been improved with 
CBT (43).
Transference focused psychotherapy. Transference-
focused psychotherapy (TFP) is a manualized, evidence-
based treatment for borderline and other severe perso-
nality disorders that is based on psychoanalytic object 
relations theory. The treatment contracting/setting the 
frame, managing countertransference, and the interpre-
tative process are 3 critical components of TFP (44). It 
is used to treat borderline personality disorders (45), 
which is often the personality disorder underlying SISL.
Psychoeducation
Psychoeducation has not really been studied in patients 
with SILS, although it is important for understanding 
skin reactions. The stress-symptom axis, tension-relief 
relaxation, problem-solving in helpless situations and 
neurogenic inflammation may offer additional explana-
tions for the unknown origin of some skin symptoms. In 
PTSD, habit reversal techniques (see further on), skills 
training and avoidance of triggering situations could 
achieve positive results. 
Relaxation techniques
In general, relaxation techniques involve refocusing 
attention, concentrating on tranquillity and increasing 
awareness of the body. Relaxation was one of the first 
non-pharmacological treatments recommended by der-
matologists (46). However, the use of relaxation as a 
stand-alone therapy seems to have a little effect on stress, 
anxiety and depression (47). Relaxation techniques in-
clude: autogenic relaxation (Shultz); progressive muscle 
relaxation (Jacobson); visualization; and deep breathing. 
They can be combined or present overlapping features 
with other similar therapeutic approaches, such as hyp-
nosis, massage, meditation, Tai chi, yoga, biofeedback, 
music and art-therapy. Relaxation techniques are a main 
component of CBT and in habit reversal.
SPECIFIC THERAPEUTIC APPROACHES TO 
SELF-INFLICTED SKIN LESIONS 
SISL classification 
The SISL classification proposed by the ESDaP Group 
defines 4 main categories (1):
• Non-hidden and non-denied underlying behaviour: 
skin picking and related skin damaging symptoms – 
compulsive spectrum.
• Non-hidden and non-denied underlying behaviour: 
skin picking and related skin damaging symptoms – 
impulsive spectrum.
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• Hidden or denied underlying behaviour with no ex-
ternal incentives: factitious disorders in dermatology.
• Hidden or denied underlying behaviour with external 
incentives: malingering in dermatology.
This sequence of clinical categories will be followed 
to offer recommended or specific therapeutic approaches 
in SISL.
RECOMMENDATIONS AND SPECIFIC TECH-
NIQUES FOR THE MANAGEMENT OF SELF-
INFLICTED SKIN LESIONS 
Skin picking and related skin damaging syndromes – 
compulsive spectrum
The compulsive spectrum of SISL indicates obsessive-
compulsive behaviours as the cause of the skin symp-
toms. Examples of such behaviour would be face picking 
(acne excoriée), nose picking, trichotillomania and 
onychotillomania. 
Comorbidities
There may be skin lesions (e.g. acne excoriée) before 
onset of the obsessive-compulsive behaviour although 
patients can start skin picking with no previous skin 
lesions (e.g. onychotillomania). The most frequent un-
derlying comorbidities are: anxiety disorders (including 
the whole spectrum of OCD); depression; dissociation 
disorders; obsessive-compulsive personality disorder; 
borderline personality disorder; and body dysmorphic 
disorder (BDD), which is related to face skin picking in 
acne excoriée. BDD is also a possible comorbid disorder 
in other compulsive skin picking syndromes, such as 
trichotillomania (48).
Communication options and emotional structure
The patient probably has an obsessive behaviour disorder 
that is easily diagnosed by the doctor on asking about 
behaviour at home or in stressful situations. Patients 
usually have feelings of shame and guilt. They are the-
refore reluctant to spontaneously disclose or admit this 
behaviour. Subjects may not trust the doctor, so the first 
step is to develop an open and confident relationship (see 
“General Principles”); non-judgmental communication 
is essential. Patients will have often tried to resist the 
behaviour, so comments like “You should stop doing it” 
are not helpful. Family members should be advised not 
to prohibit the behaviour, unless an agreement between 
the patient and his/her relative is reached which helps 
the patient to be aware of the behaviour; if the repetitive 
behaviour occurs when the patient is in a state of altered 
consciousness (dissociative state), external support can 
be useful.
Doctor–patient communication should be aimed at 
shared decision-making regarding options for avoiding 
the obsessive behaviour and focusing on the emotions 
of guilt and shame. A basic therapy option is the beha-
vioural analysis of the situations where the obsessive 
behaviour arises or the identification of specific emotions 
or thoughts that lead to the skin lesions. Naming and defi-
ning the obsessive-compulsive mechanism can provide 
relief for the patient (this is not the case with factitious 
disorders). Suicidal ideation and attempted suicide are 
not frequent with this type of SISL.
Specific therapeutic options
• Dermatological treatment: dermatologists should em-
ploy their usual treatment strategies but must be aware 
that they (alone) may not be sufficient. A systemic 
treatment, such as isotretinoin, is not recommended 
if severe depression has already been diagnosed. Ca-
reful cleaning and good hygiene (anti-acne) can help 
avoid face picking (acne excoriée). The cosmetician, 
dermatologist, aesthetician or nurse should manage 
the skin (not the patient). With hair pulling, hair 
medication or special hair cosmetics are not recom-
mended unless there is infection. The same is true for 
onychotillomania, unless dressing the nails at times 
when the behaviour occurs (usually in the evening or 
in stressful situations). Artificial nails, manicure and 
other cosmetic options may be considered. 
• Antidepressants: with underlying anxiety disorders, 
including obsessive-compulsive behaviour, antide-
pressant drugs, especially SSRIs, are recommended 
(49). Some recent studies (not well controlled and not 
randomized) have indicated that fluoxetine and venla-
faxine may produce positive results with skin picking 
(50–52), although a double-bind trial of fluoxetine in 
pathological skin picking did not demonstrate signi-
ficant efficacy. Case-controlled studies have analysed 
antidepressant therapy with hair pulling (see below). 
• Other psychotropic drugs: antiepileptic drug therapy 
with oxcarbazepine was shown to have limited success 
(53) in trichotillomania patients; Van Ameringen et al. 
(54) reported positive results using neuroleptic olan-
zapine for the same condition. The use of these drugs 
should always take the possible side-effects (obesity 
and overweight) into account. N-acetyl cysteine has 
also shown some promising results, not only in classi-
cal OCD, but also in pathological skin picking (23–25).
Cognitive behavioural therapy
In general, studies indicate that cognitive behavioural 
therapy for skin picking is the most effective treatment. 
Stein et al. (55) advanced the “A-B-C model” of habit 
reversal for hair pulling and skin picking (“A” – affect 
regulation; “B” – behavioural addiction; “C” – cognitive 
control).
The “habit-reversal therapy” for trichotillomania 
consists of 4 main components: (i) self-monitoring 
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(the patient keeps a record of hair-pulling behaviour), 
(ii) awareness training (increasing patient’s awareness 
of both hair-pulling behaviour and high-risk situations 
that frequently trigger hair-pulling behaviours), (iii) 
stimulus control (techniques dedicated either to de-
crease opportunities to pull hair or to interfere with 
or prevent pulling, as for example wearing gloves in 
high-risk situations), and (iv) stimulus-response inter-
vention (developing activities to substitute, such as deep 
muscle relaxation or taking a walk, when the desire for 
hair pulling occurs) or competing response intervention 
(engaging in a physically incompatible behaviour to the 
pulling for a short fixed period of time or until the urge 
goes away) (55–57). 
Habit reversal techniques aimed at stopping the OCD 
seem to have positive outcomes: in 2006, Teng et al. 
(58) undertook a pilot investigation on habit reversal 
treatment in chronic skin picking and Twohig et al. 
(59) studied acceptance and commitment therapy as a 
treatment for the same problem. However, few scientific 
papers with small numbers of patients have been publis-
hed, thus evidence is limited.
Cognitive interaction using a diary (as with food 
allergy sufferers) is another option for establishing 
more conscious self-treatment. The positive cognition 
increases when the patient and the dermatologist jointly 
set the goal of desisting from the skin picking or hair 
pulling behaviour; for example a 2- or 3-day period 
could be agreed, if the patient complies then they may 
give themselves some kind of reward. 
If the dermatologist feels it is impossible to introduce 
these kinds of therapy options, a mental health specialist 
should be contacted. The organization of a team that 
includes a general practitioner, a mental health profes-
sional, specialist nurses, etc. is recommended. 
A systematic meta-analysis published in 2007, based 
on 7 randomized studies comparing pharmacological 
(clomipramine or SSRIs) and behavioural treatments 
(habit reversal therapy) for trichotillomania demonstrated 
that the effect size of habit reversal therapy was superior 
to pharmacotherapy. Furthermore, it demonstrated that 
only clomipramine (not SSRIs), was superior to placebo 
(57). A more recent meta-analysis published in 2014 by 
McGuire et al. (60) confirms the superiority of beha-
viour therapy to pharmacological treatments; especially 
for behaviour therapy trials that used mood-enhanced 
therapeutic techniques. Clomipramine exhibited larger 
effect sizes relative to SSRIs, but the difference was not 
statistically significant.
If there are life-long problems, specific problems with 
emotional communication, or if underlying anxieties 
appear, patients with acne excoriée, trichotillomania or 
another disorder belonging to the compulsive spectrum of 
SISL might benefit from psychodynamic psychotherapy. 
This of course will depend on the time-frame and the 
availability of such therapists. 
Prognostic aspects
If patients are able to accept the diagnosis of OCD the 
prognosis is generally favourable. Non-acceptance may 
indicate more severe personality problems and the spe-
cific therapeutic aspects of SISL should be considered. 
The relationship with the dermatologist is probably the 
most important prognostic factor. The presence of an 
impulsive component in compulsive type skin picking 
disorders is generally considered as an index of severity 
(61) and pushes some psychiatrists to support the catego-
rization of skin picking disorders as an impulsive control 
disorder, rather than an obsessive compulsive related 
disorder (62). The phenomenology of trichotillomania 
and pathological skin picking, especially the fact that 
these behaviours are not always triggered by obsessional 
thoughts and can begin without the person’s awareness, 
contrarily to classical OCD, led some authors to reject 
the DSM-5’s new category of obsessive-compulsive and 
related disorders (OCRDs) and along with its content on 
both scientific and logical grounds (63). 
Skin picking and related skin damaging syndromes – 
impulsive spectrum
As mentioned by the ESDaP group, impulsive skin 
picking and related skin damaging syndromes are acts 
of uncontrolled aggression to the skin. These behaviours 
frequently offer rapid, but short-lived, relief from a va-
riety of intolerable conditions, providing vital support for 
the patient, aiding their psychological survival, albeit in 
a pathological state” (1). This spectrum of disorders is 
most common in adolescence. 
Comorbidities
Impulsive skin picking usually involves more personality 
disorders than the obsessive-compulsive type; borderline 
personality disorders, narcissistic personality syndro-
mes and antisocial personality disorders are frequent. 
Substance abuse, risk-taking behaviour (binge drinking, 
illegal drug use, promiscuity, unprotected sex, etc.) 
and eating disorders could also be present. A history of 
sexual, physical and/or emotional abuse (especially in 
childhood and puberty) with post-traumatic stress may 
have impaired the emotional regulation capacity of these 
subjects. Less severe impulsive SISLs can correlate with 
mood disorders.
Communication options and emotional structure
Impulsive-type SISL lesions can also be referred to as 
“non-suicidal self-injury”: the deliberate, direct destruc-
tion of body tissue without conscious suicidal intent. 
The most common forms are biting, cutting, scratching, 
hitting and burning. These kinds of self-injuries are not 
specific to psychiatric populations, although they are 
more frequent in this group. In 2007, an observational 
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study on a population of adolescents (6) found that up 
to 46.5% had committed some form of non-suicidal 
self-injury during the past year and 28% were moderate 
or severe cases. This high prevalence of non-suicidal 
self-injury observed in a community sample, and not in 
clinical population, indicates that this phenomenon can 
be overlooked unless open-ended questions are tactfully 
asked to inquire about the behaviour. Therefore, it is im-
portant to have established a relationship of trust before 
approaching these issues. In general, there is a tendency 
among young people to trivialize this behaviour, which 
can range from minor to severe self-injury. Minor self-
injury is often not recognized or may be denied as patho-
logical behaviour as it would correspond to a normative 
expression of teen culture. However, moderate and severe 
forms are generally associated with personality disorders 
and other self-harm behaviours, such as drug abuse, 
eating disorders, risk taking behaviour, bone breaking, 
falling, jumping, etc., as well as suicidal ideation and 
suicidal attempts. Some authors (64–66) have tried to 
attribute multiple functions to non-suicidal self-injury, 
such as to relieve negative emotions, to relieve negative 
thoughts, to self-punish, to set boundaries with others, 
to feel something (even if it is pain), to provide a sense 
of security or control, to get attention, etc. Of course, 
puberty is accompanied by body transformations and 
sexual arousal, which can be difficult to handle and con-
tain for some, and may lead to self-inflicted behaviours 
as a mean of tension relief. Males seem more likely to 
self-harm as a means to communicate or influence others; 
females are more likely to engage in self-harm for relief 
of intra-punitive issues, such as self-hatred, depression 
or loneliness. Aside from gender differences, it appears 
that positive and negative reinforcement and acceptance 
incite repetition, trivialization and amplification of non-
suicidal self-injury behaviour. 
Specific therapeutic options
After unambiguous diagnosis and definition of the type 
of impulsive behaviour, the first step is to discuss the dif-
ferent options for ending the harmful behaviour. Unlike 
obsessive-compulsive behaviour, the impulsive state is 
not repeated chronically. It is also unusual for the patient 
to harbour feelings of shame or guilt. 
Patients are generally willing to talk about their impul-
sive behaviour. Relief of tension is a typical motivator 
and the physician should raise this issue, as it is possible 
that the patient will not be aware of it. Some patients are 
not psychologically disturbed, but indulge in impulsive 
self-harm in imitation of their peer-group without under-
standing the potential long-lasting effects of scars and 
wounds. Intolerance and frustration could be the cause 
of the impulsive behaviour. 
Impulsive behaviour is also characteristic of patients 
with severe destructive personality problems: borderline 
personality disorders, narcissistic personality disorders 
and PTSD in which the impulsive self-harm is only one 
symptom of the condition. 
Impulsive-type SISLs can be considered as a risk 
factor for suicide, especially in male adolescents (67). 
Suicidal ideation and suicide attempts are much more 
frequent with this type of self-harm, and the physician 
should always take this into account when dealing with 
the patient (see general principals on suicidal ideation 
management). Sometimes the impulsive-type of skin 
lesion, even if it is not a severe dermatological symptom, 
can be the final signal from the patient before suicide 
is attempted; a self-harm risk assessment is therefore 
recommended. 
• Dermatological treatment. There is no specific derma-
tological treatment for the impulsive spectrum of SISL. 
Patients will often come to the dermatologist for the 
treatment of scars or another skin problem and the skin 
picking behaviour will appear as secondary symptom. 
Asking for help with the scars is a positive sign for the 
prognosis; topical treatment should be offered.
• Psychotropic drugs treatment for impulsive spectrum 
of SISL. As with borderline personality disorders, 
antipsychotics can reduce tension and control impul-
siveness. Adherence can be a problem and compliance 
is often poor. If psychotropic drugs are indicated, 
the dermatologist should liaise with a mental health 
specialist: risperidone, promethazine, carbamazepine, 
haloperidol, valproate acid, starting at low dosages are 
clinically employed. A Cochrane review (68) states that 
studies with antidepressants (mianserin, nomifensine, 
paroxetine) compared with placebo controls, found no 
evidence of a reduction of self-harm behaviour. 
• Psychotherapy in impulsive spectrum of SISL. The 
psychotherapeutic treatment of the impulsive type of 
SISL is made more difficult when patients trivialize 
their problems. However, psychotherapy seems to be 
the most effective long-term treatment option. The 
role of the dermatologist is vital for motivating and 
encouraging the patient with this kind of therapy.
A cognitive behavioural approach could begin with 
a discussion on impulsive situations, with the aim of 
determining emotional triggers for the actions. This 
could lead to a strategy for dealing with the “point of no 
return” some minutes or seconds before the self-harm 
begins (squeezing a small ball in the hand; pinching 
the skin; pulling an elastic band to the skin at the arm/
hand; putting emotions in a “safe place”, the “treasure 
box philosophy”; turning attention to external stimuli; 
communicating with others etc.). 
Linehan’s dialectic behavioural therapy (69) and 
transference-focused psychotherapy (44) for borderline 
personality disorders are recommended. A mindfulness-
based approach (70) is another option for psychotherapy. 
In adolescents, family therapy should be considered, 
especially if eating disorders are also present.
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Prognostic aspects
The first-line goal should be to lower the frequency of the 
impulsive behaviour. Without therapy, the prognosis is 
poor, suicidal ideation and suicide attempts are common 
and the self-harm will probably continue (in approxima-
tely 46.5% of patients, according to Lloyd-Richardson et 
al. (6). If patients have access to, and are able to accept 
mental health treatment, the prognosis is positive, but 
this obviously depends on the severity of the underlying 
personality problems. 
FACTITIOUS DISORDERS IN DERMATOLOGY 
Factitious disorders in dermatology are defined as the 
induction of skin lesions by the patient: this induction 
is kept secret until an appropriate relationship with 
a caregiver is established. The subject may be aware 
that he or she is driven to create the lesions, or in some 
instances the activity may take place in a dissociative 
state outside the patient’s awareness. Dermatitis arte-
facta, factitious dermatitis or dermatitis factitious are 
often synonymously referred to as factitious disorders. 
We already recommended the avoidance of these terms 
and their replacement by the term “factitious disorders 
in dermatology”, since dermatitis suggests underlying 
inflammation (1). Lesions are usually seen in areas that 
are available to the handedness of the patient; the most 
frequently affected sites are the face, arms and legs. 
Factitious disorders can also occur in children and adol-
escents, but this syndrome has to be differentiated from 
Polle’s syndrome or Munchausen syndrome by proxy, 
where a subject, most often the mother, may artificially 
cause a skin disease in her own child.
The main motivation is assumed to be a method for 
coping with a severe psychological background and a 
preference for the sick role with no immediate tangible 
benefits. Factitious disorders in dermatology are at least 
twice as frequent in women as in men.
Comorbidities
Cutaneous lesions can be accompanied by other facti-
tious disorders; for example, a chronic fever due to the 
manipulation of the thermometer. These associations 
may complicate and delay the diagnosis, which is always 
difficult to establish.
Patients presenting factitious symptoms sometimes 
describe demonstrative and dramatic problems and give 
false information on their medical history (“pseudolo-
gia fantastica”); they may speak of many hospital stays 
and show numerous scars from surgical procedures 
(“doctor and hospital shopping”). This is characteristic 
of Munchausen’s syndrome, a clinical subtype of facti-
tious disorders, more frequent in men than in women. In 
Munchausen’s syndrome, self-harm is often delegated to 
the care providers. 
Borderline personality disorder, substance abuse, 
somatoform pain disorder, conversion disorders, sexual 
disorders, dysthymia and suicide attempts are frequently 
associated with factitious disorders (71, 72). Substance 
abuse, eating disorders and personality disorders are 
more frequently associated with factitious disorders 
involving direct self-harm (scratching, cutting, burning) 
than in those involving indirect self-harm (use of medica-
tion, chemicals or infectious substances); in these cases, 
anxiety disorders, adaptation disorders and somatoform 
disorders are more frequent. Mood disorders seem to 
be common in both types of factitious disorders (73). 
Depression can precede the onset of a factitious disorder. 
Patients with borderline personality disorder have 
often experienced abandonment, family separation or 
hospitalization in their childhood, resulting in intense 
affective dependency, which explains the sensitivity 
of these patents to separation, mourning and emotional 
disappointment. These situations very often re-open old 
wounds of abandonment. Concomitant or family physical 
disease (especially if it affects a close family member) 
is a common association (74).
Some participants in the ESDaP Group suggest the 
possibility of a paranoid personality when a factitious 
disease occurs in a man.
Communication options and emotional structure
Communication between the patient and the healthcare 
providers. Patients with a factitious disease often model 
their relationship with the doctor on relationships they 
have had with parental figures or relatives. They may 
see any close relationship as bearing a threat of betrayal, 
abandonment and even aggression. This can explain the 
ambivalent attitude of many factitious disorder patients 
towards their physicians. Although a good initial relation-
ship may develop, sufferers will demand more and more 
attention, care, and medication. This is often followed 
by disappointment, ignorance and even an accusatory 
attitude; expectation and rejection, love and hate, may 
therefore coexist. The effects produced by a factitious 
skin disorder on others will reproduce this ambivalence. 
Damaged skin represents both a call for help, an appeal 
for care and love, and a means of distancing from others, 
defying and aggressively manipulating those who are 
perceived as unreliable or even dangerous. 
It has been suggested that patients with a factitious skin 
lesion seek painful sensations to create an “envelope” of 
suffering to restore their bodily and psychological boun-
daries, which they perceive as damaged. By damaging 
their skin and by lying about the cause of their “skin di-
sease”, patients with factitious skin lesions not only reset 
their own limits, but also acquire an identity: a “surface 
identity” or “patient identity” that is a camouflage for 
their internal emptiness. Through illness, the subject 
may establish a relationship, if only with a healthcare 
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provider. The healthcare provider will provide the patient 
with the skin and body care that was acutely inadequate 
or completely lacking in childhood. 
Patient–dermatologist communication. It can be dif-
ficult for the dermatologist to accept that a patient is 
responsible for their own lesions; acknowledgement 
means jeopardizing the doctor–patient relationship as the 
physician may feel that they have been manipulated. Ho-
wever, avoiding this possibility risks the reinforcement 
of the patient’s position, allowing them to believe in the 
reality of their condition and this, in turn, can strengthen 
the patient’s masochism and cause them to increase the 
production of lesions. 
If the dermatologist is capable of contemplating the 
possibility of psychological suffering and understanding 
that self-produced lesions are the expression of that suf-
fering, it is easier to diagnose a factitious disorder. This 
enables early diagnosis and avoids the deterioration of 
the doctor–patient relationship. In a hospital setting, su-
pervision by an external mental health professional (for 
example, a psychoanalytical supervisor) can improve 
screening for factitious disorders (73).
If a dermatologist does not feel sufficiently confident 
to manage the psychological aspects of a skin condition 
that they suspect is self-produced, they should (at least 
in the initial stages) refer the patient to a dermatologist 
that is more experienced in this pathology, or to a psy-
chiatrist–psychotherapist or psychologist. This should 
be done as soon as possible because a late referral to a 
mental health specialist may cause the therapist to be 
viewed as the person who forces the patient to admit 
to self-harm. Patients with factitious skin lesions rarely 
refuse a first meeting with a psychiatrist–psychotherapist 
or psychologist, as long as they do not feel rejected by 
their dermatologist.
Screening and objectively identifying a depressive 
condition is a means for the dermatologist to broach the 
subject of the psychological and emotional state of the 
patient with a factitious skin lesion and it may be used as 
the basis of a request for help to a mental health specialist. 
Attempts should be made to adhere to appointment 
schedules and to create a safe and accepting environment 
during the consultation (74). It is preferable to avoid 
any reference to the physical mechanisms causing the 
lesions, and to focus on “stress” as the probable medi-
ator; this may be easier for the patient to accept and could 
be a rationale for the introduction of psychotherapy or 
a psychiatric consultation. Referring to a mental health 
specialist could be interpreted as a subtle means to force 
the patient to confess responsibility for the lesions.
Communication between a dermatologist and healthcare 
teams. When a person with a factitious skin lesion is 
hospitalized, the healthcare team must work together to 
determine a common approach and to maintain the links 
between the various healthcare providers; they should 
also offer support to fellow workers and deal with any 
feelings of irritation, aggression or rejection towards the 
patient that can be caused by a sense of manipulation and 
ambivalence. If these feelings are not addressed, they 
can lead to the prescription of unnecessary medication or 
even surgical procedures that could be dangerous for the 
patient. This could ultimately result in the development 
of a sadomasochistic relationship between the factitious 
skin lesion patient and the healthcare provider.
Communication between the dermatologists, patient’s re-
latives and his/her general practitioner. Precautions must 
be taken when informing relatives (and even the patient’s 
general practitioner), of the condition. The dermatologist 
should emphasize the seriousness of the psychological 
suffering that is expressed through the SISL. Relations-
hips with relatives can be uncomfortable: the family are 
often angry and accusatory and believe that the physician 
is incompetent (75). The relatives may have noticed the 
suffering of the patient and can play a role as a mediator 
in resolving family conflicts. It is important that the rela-
tives are not told that it is the patient that is responsible 
for their own lesions (unless this is first suggested by the 
relatives themselves). Dermatologists should be aware 
that some general practitioners are reluctant to consider 
the possibility of a SISL and may tell the patient that the 
diagnosis of self-harm is the idea of the dermatologist, 
thereby jeopardizing the therapeutic approach.
Specific therapeutic options
Factitious cutaneous disorders are probably the most 
complex of all self-inflicted skin lesions. Treatment 
objectives are more easily achieved when the dermato-
logist is non-judgmental about the patient’s condition 
and has acquired specific skills for treating it. There are 
very few publications that encourage the physician to 
confront patients suspected of self-harm behaviour: most 
authors argue that conflict is counter-productive and even 
dangerous (76–78). Aggravation of the lesions, breaking 
contact with the healthcare team, becoming delirious and 
even suicide have been reported in cases where patients 
have been directly questioned on their responsibility for 
the lesions.
Dermatological treatment is of particular importance 
with factitious skin lesions because the underlying causes 
are not usually hidden or denied. Occlusive dressings 
(especially standard plaster casts), which allow the skin 
lesions to heal completely (confirming self-infliction) 
may be applied and local treatments such as antiseptic 
solutions, antibiotic ointments and healing ointments 
may be prescribed. After antimicrobial susceptibility 
testing, antibiotics may be used to treat secondary infec-
tions of the skin, subcutaneous tissues and, occasionally, 
bacteraemia or septicaemia. 
Surgical procedures that are often requested by pa-
tients with Munchausen’s syndrome should be avoided. 
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Reparative plastic surgery should only be considered in 
collaboration with a psychiatrist-psychotherapist, only 
after the skin has healed and on the condition that a 
marked improvement has been observed in the patient’s 
psychological state. 
Antidepressants can be useful with associated de-
pressive syndromes and for encouraging the patient to 
accept a psychological approach. Tranquillizers and 
antipsychotics can treat underlying impulsiveness or 
emotion regulation disorders, especially in cases of 
severe comorbid personality disorders, but they should 
only be used after careful consideration: there is a risk 
of abuse and of damaging the trust that has been built 
up between the doctor and patient.
Several, previously described, approaches for mana-
ging borderline personality disorders underlying SISL 
can be applied. The therapist must have experience in 
treating this type of condition and be able to adapt to the 
very special personality of patients with factitious disor-
ders; progress is slow and sufferers have great difficulties 
in verbalizing their feelings and conflicts. 
In contrast to the defeatist position found in some 
publications (79, 80), the ESDaP Group believes that a 
psychological and psychodynamic approach can be suc-
cessful with these patients, as long as the psychotherapist 
is convinced of the possibility of success and is prepared 
to persevere (81). The psychotherapist’s awareness of 
counter-transference feelings and support or individual 
supervision in the follow-up period can result in more 
positive outcomes.
Prognostic aspects
In adolescents, factitious disorders often represent “a 
cry for help”. In general, the early onset of a factitious 
disorder has a better prognosis than late onset. This is 
also true with mild forms of factitious skin lesions and in 
cases in which the lesions are produced in a dissociated 
state. As always, the quality of the psychotherapeutic 
relationship is a significant factor.
MALINGERING IN DERMATOLOGY 
Malingering is the production or feigning of a well-
known symptom or lesion by the patient. The patient 
is aware that the lesion is self-inflicted, but will deny 
responsibility with the aim of gaining a social or financial 
advantage. In dermatology, patients may intentionally 
aggravate the symptoms of pre-existing skin conditions, 
but they may also cause de novo skin lesions. The term 
“malingering” is often used to describe the aggravation 
of a pre-existing lesion, whilst “simulation” refers to 
feigning a subjective symptom or the creation of a new 
lesion. There will be no prior history of self-harm and 
the patient will rarely admit to the behaviour. The doc-
tor–patient relationship is therefore complicated and the 
first step is to validate diagnosis (careful observation of 
the patient’s behaviour, dressings that make self-harm 
more difficult, etc.). 
Comorbidities
Comorbidities cover the full spectrum of personality 
disorders, especially antisocial personality disorders 
and Munchausen’s syndrome. An illustrative example 
would be a real-life case that was brought before one 
of the authors of this paper: a middle-aged woman with 
an allergy to bee stings suffered sexual abuse at her job, 
she deliberately instigated contact with the insects (her 
husband was an apiculturist) and the presentation of the 
consequent symptoms of anaphylaxis and Quincke’s 
oedema meant she was able to avoid work. It took a 
number of years before this was recognized and the 
patient was able to discuss the problem. 
Communication options and emotional structure
Communication should be aimed at offering comfort 
and suggesting explanations for the condition. The ob-
jective is that the patient becomes able to disclose and 
talk about the underlying problem. Collaboration with 
the general practitioner and other health professionals 
is recommended. 
Specific therapeutic options
No specific therapy options have been described for 
malingering. Each case is different and an individual 
approach with close supervision is advisable. 
Prognostic aspects
If the patient cannot be convinced to undergo therapy, 
the prognosis is not favourable. 
CONCLUSION
Dermatologists often lack therapeutic strategies for 
dealing with patients who present SISL. This article 
aims to help dermatologists without psychotherapeutic 
training to deal with such patients. Ideally, treatment 
should be initiated during the dermatology consulta-
tion, and delaying this treatment may lead to repetitive 
behaviour, making it more and more difficult to treat. 
The therapeutic recommendations put forward in this 
paper are based on the review of the literature and on the 
experience of a group of dermatologists, in collaboration 
with mental health specialists. These recommendations 
are not exhaustive, but they are known to be effective. 
For example, until now, very little has been written 
about the family members of self-harm patients and 
the potential benefits of family therapy. More research, 
based on the classification, using prospective and com-
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parative studies is needed to refine the strategies for each 
condition. However, as the doctor–patient relationship 
is the cornerstone for improvement, comparison is so-
mewhat complex. If new studies can be developed that 
employ diagnostics with reference to the classification, 
a more accurate prognosis for each type of SISL may 
be forthcoming, something that is clearly lacking in the 
literature. These studies would also help to confirm that 
the classification is functioning in the day-to-day work 
of the dermatologist. 
The authors declare no conflicts of interest.
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